Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to 36.7%.

  • Sotera Health's EBIT Margin rose 85000.0% to 36.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.29%, marking a year-over-year increase of 42300.0%. This contributed to the annual value of 27.05% for FY2024, which is 6800.0% up from last year.
  • Sotera Health's EBIT Margin amounted to 36.7% in Q3 2025, which was up 85000.0% from 33.2% recorded in Q2 2025.
  • Over the past 5 years, Sotera Health's EBIT Margin peaked at 36.7% during Q3 2025, and registered a low of 15.13% during Q1 2023.
  • For the 5-year period, Sotera Health's EBIT Margin averaged around 27.17%, with its median value being 27.77% (2024).
  • Data for Sotera Health's EBIT Margin shows a peak YoY increase of 96200bps (in 2023) and a maximum YoY decrease of -74700bps (in 2023) over the last 5 years.
  • Sotera Health's EBIT Margin (Quarter) stood at 27.53% in 2021, then fell by -13bps to 23.92% in 2022, then skyrocketed by 40bps to 33.53% in 2023, then fell by -10bps to 30.03% in 2024, then increased by 22bps to 36.7% in 2025.
  • Its EBIT Margin was 36.7% in Q3 2025, compared to 33.2% in Q2 2025 and 28.43% in Q1 2025.